NCT03327012

Efficacy and Safety of Panlongqi Tablet in Patients With Knee Osteoarthritis

Efficacy and Safety of Panlongqi Tablet in Patients With Knee Osteoarthritis:A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel Study

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
• Sex: All
• Age: 40 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the efficacy and safety of Panlongqi tablet compared with placebo in the treatment of knee osteoarthritis in adults.Half of participants will receive Panlongqi tablet in combination,while the other half will receive a Placebo.

Detailed description

The test group will be given Panlongqi tablet 1.2g three times per day,the control group will be given placebo 1.2g three times per day. The invention will last 4 weeks.

Conditions

• Knee Osteoarthritis

Interventions

Type	Name	Description
DRUG	Treatment of Panlongqi Tablet	Panlongqi Tablet:1.2g,3times a day, oral, for 4 weeks.
DRUG	Treatment of Panlongqi placebo	Panlongqi placebo:1.2g,3times a day, oral, for 4 weeks.

Timeline

• Start date: 2017-11-01
• Primary completion: 2019-03-28
• Completion: 2019-07-28
• First posted: 2017-10-31
• Last updated: 2017-10-31

Locations

1 site across 1 country: China